Page 1

The report for Global Orphan Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Global Orphan Drugs Market are drugs used for the treatment of rare diseases and disorders that affects a small percentage of the population. There are approximately 7,000 different types of rare diseases and disorders and an estimated 30 million people in the United States, 30 million in Europe and 350 million people worldwide suffer from rare disease. Four fifth of rare diseases are genetic in origin, with 50% of the people affected being children. The distribution of rare diseases is skewed with four fifth cases accounted by some 350 rare diseases. Only 5% of rare diseases have approved drug treatment with only 326 new drugs being approved by the FDA and brought to market. In 2015, orphan drug sales were of the order of 93 billion. Orphan drugs, represented 35% of the industry’s new drug approvals. The $93 billion (2015) Global Orphan Drug Market, is projected to reach $200 billion in 2022, reflecting a compound annual growth rate (CAGR) of 11.56%. The revenues of biological orphan drug market and non-biological drug market will be 142.85 billion and 57.14 billion respectively in 2022. The major driving factor for the growth are unmet needs for rare diseases and the growing investment in research and development, legislative, economic and tax benefits provided by governments, high return on investment, development of new technologies such as DNA recombinant, hybridoma and gene mapping, faster uptake and low marketing cost and extensive exclusivity. However constraints such as high cost of development followed by costly clinical trials and extensive post market surveillance, monopolized and unitary market, competition from generics and biosimilars, and concern over the safety are threats which have to be managed. Active commercialization and distribution can be hindered by the differential availability of developed and developing countries due to social and economic factors. Access Demo Copy at . Key Players for Global orphan drugs Market: Hoffmann- La Roche, Celgene Corporation, Alexion Pharmaceuticals, Inc., Novartis AG, Takeda Pharmaceuticals Company Limited, Biogen Idec Limited, and Eli Lilly, Bristol-Myers Squibb, Vertex pharmaceuticals, Inc. Bayer AG, Sanofi, and Johnson & Johnson. Segments:

Global orphan drugs market has been segmented on the basis of pharmacological class, applications, technology, source and region. Regional Analysis of Global orphan drugs Market: Globally North America is the largest market for Global orphan drugs. Europe is the secondlargest market for Global orphan drugs. The near future market for orphan drugs will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. Table of Contents 1 Introduction 2 Research Methodology 3 Market Dynamics 4 Market Factor Analysis 5 Global Orphan Drugs Market, By Application 6 Global Orphan Drugs Market, By Pharmacological Class 7 Global Orphan Drugs Market, By Technology 8 Global Orphan Drugs Market, By Source 9 Global Orphan Drugs Market, By Regions 10 Company Landscape 11 Company Profile …Continued Get Discount at . Top Reasons to Buy the Reports:  Company profiling with detailed strategies, financials, and recent development activities  Market Strategic Business Influence Data  Market Research Future recommendations in key business segments based on the market estimations  Market share analysis of the top industry players  Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact: Market Research Future +1 646 845 9312


Orphan Drugs Market new booming trends in 2022  
Orphan Drugs Market new booming trends in 2022